AUPH
AUPH
CA05156V1022
Aurinia Pharmaceuticals Inc
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 283.055.000 235.133.000
20.4%
Cost of Revenue 32.665.000 28.248.000
15.6%
Gross Profit 250.390.000 206.885.000
21.0%
143.829.000 188.466.000
23.7%
Operating Income 106.561.000 18.419.000
478.5%
Pretax Income 114.157.000 7.448.000
1432.7%
Net Income Common Stockholders 287.202.000 5.752.000
4893.1%
-- --
--
-- --
--
ende